Diabetes Drug Injected Weekly Wins FDA Approval - New York Times
Posted by admin! / Under Diabetes
 MyFox Houston | Diabetes Drug Injected Weekly Wins FDA Approval New York Times Amylin Pharmaceuticals won federal approval on Friday for its new, more convenient drug for Type 2 diabetes, ending years of setbacks. The drug, Bydureon, is injected once a week. Its main competitor is expected to be Novo Nordisk's Victoza, ... FDA Approves Amylin's Bydureon Diabetes Drug Amylin's long-delayed diabetes drug gets FDA nod Weekly Shot Gets FDA Nod for Type 2 Diabetes |
Published on Saturday 28th of January 2012 01:39:54 AM
